The life sciences industry is at the epicenter of seismic change. Even before the accelerating effects of the global pandemic, patient demand for personalized medicines and therapies was growing. Regulatory pressures on health, energy, and sustainability continued to build. Supply chains were becoming more complex with a network of research partners, co-manufacturers, and global suppliers.
![Life Sciences: An Industry Facing Supply Chain Disruption b85bfe08-2102-49ea-a5ed-c833ce4ffb5e](https://itvue.file.core.windows.net/assets/b85bfe08-2102-49ea-a5ed-c833ce4ffb5e_thumb.jpg?sv=2019-02-02&sr=f&sig=Lxkh99t1uAxQEsal4AaR1mMbeomYlHhHe0sbeWNmlY4%3D&st=2024-09-08T00%3A57%3A02Z&se=2024-09-09T00%3A58%3A02Z&sp=r&rscc=no-cache%2C%20no-store%2C%20must-revalidate)